H. Parker
Chairman at SANGAMO THERAPEUTICS, INC.
Net worth: 216 568 $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Stephen Dilly | M | 64 | 14 years | |
| John Bencich | M | 47 | 10 years | |
| Mark Velleca | M | 60 |
StrideBio, Inc.
 StrideBio, Inc. BiotechnologyHealth Technology Stridebio, Inc. focuses on creating and developing novel adeno-associated viral vector technologies. The company was founded by Aravind Asokan, Mavis Agbandje-McKenna and Patrick Ritschel and is headquartered in Durham, NC. | 2 years |
| Anthony Clarke | M | 68 | 9 years | |
| Margaret Fitzgerald | F | 53 | 2 years | |
| Robin Kramer | F | 58 | 4 years | |
| Richard J. Bastiani | M | 81 |
C3J Therapeutics, Inc.
 C3J Therapeutics, Inc. BiotechnologyHealth Technology C3J Therapeutics, Inc. operates as a biotechnology company. It focuses on the discovery and development of novel targeted antimicrobials-synthetic bacteriophage and antimicrobial peptides. The company was founded by Randal Eckert, Maxwell H. Anderson and Wenyuan Shi in 2005 and is headquartered in Marina del Rey, CA. | 11 years |
| Prathyusha Durabaibu | F | 46 | 5 years | |
| Byron Dorgan | M | 81 | 13 years | |
| Aravind Asokan | M | - |
StrideBio, Inc.
StrideBio, Inc. BiotechnologyHealth Technology Stridebio, Inc. focuses on creating and developing novel adeno-associated viral vector technologies. The company was founded by Aravind Asokan, Mavis Agbandje-McKenna and Patrick Ritschel and is headquartered in Durham, NC. | - |
| Alexander Macrae | M | 61 | 8 years | |
| Richard Stewart | M | 65 | 9 years | |
| Rahul Singhvi | M | 59 | 2 years | |
| Bridget Martell | M | 58 | 4 years | |
| Karen Smith | M | 56 | 6 years | |
| Margaret Philip | F | - |
Global Partnerships
 Global Partnerships Financial ConglomeratesFinance Global Partnerships invests in partnerships with local organizations that use market-based solutions for people living in poverty. The firm invests in the areas such as health services, rural livelihoods, green technology and microentrepreneurship. The company was founded by Paula Clapp and Bill Clapp in 1994 and is headquartered in Seattle, WA. | 18 years |
| David Smith | M | 64 | 8 years | |
| Jennifer Aaker | M | 57 | 4 years | |
| Sriram Ryali | M | 43 | 1 years | |
| John Markels | M | 58 | 4 years | |
| Esther Martinborough | M | 58 | 3 years | |
| Robert Sato | M | - | 17 years | |
| Scott Willoughby | M | - | - | |
| Louise Wilkie | F | - | 4 years | |
| Phillip Ramsey | M | - | - | |
| Alison Moore | M | 57 | 4 years | |
| Todd Peterson | M | 66 | 5 years | |
| Erik Iverson | M | 56 |
Infectious Disease Research Institute
 Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Infectious Disease Research Institute operates as a innovative science to research and development company. It offers pipeline, adjuvants, vaccines, diagnostics and drugs products. The firm also provides manufacturing, analytical methods, stability studies, process and contact services. The company was founded by Steven G. Reed in 1993 and is headquartered in Seattle, WA. | 13 years |
| Diane Wilfong | F | 62 | 5 years | |
| James Meyers | M | 59 | 5 years | |
| Subhash Vinayak Kapre | M | 76 |
Inventprise LLC
 Inventprise LLC Pharmaceuticals: MajorHealth Technology Inventprise LLC is a private company that is developing vaccines against infectious diseases, with a focus on invasive pneumococcal disease, using their innovative platform technology. The company is based in Redmond, WA. The company also offers contract services in biologics, including process development, optimization, analytical services, and manufacturing from early clinical trials through commercialization. The company was founded by Subhash Vinayak Kapre, who has been the CEO since incorporation. | - |
| Sarah Schlesinger | M | 64 | 4 years | |
| Dennis Wolf | M | 71 | 17 years | |
| Michael T. Galgon | M | 56 |
Global Partnerships
Global Partnerships Financial ConglomeratesFinance Global Partnerships invests in partnerships with local organizations that use market-based solutions for people living in poverty. The firm invests in the areas such as health services, rural livelihoods, green technology and microentrepreneurship. The company was founded by Paula Clapp and Bill Clapp in 1994 and is headquartered in Seattle, WA. | - |
| Timothy Nelson | M | 60 | 7 years | |
| Ali Satvat | M | 46 | 6 years | |
| Odysseas Kostas | M | 49 | 4 years | |
| Duane A. Morris | M | 74 |
C3J Therapeutics, Inc.
C3J Therapeutics, Inc. BiotechnologyHealth Technology C3J Therapeutics, Inc. operates as a biotechnology company. It focuses on the discovery and development of novel targeted antimicrobials-synthetic bacteriophage and antimicrobial peptides. The company was founded by Randal Eckert, Maxwell H. Anderson and Wenyuan Shi in 2005 and is headquartered in Marina del Rey, CA. | 12 years |
| Joseph Patti | M | 60 | 5 years | |
| Gregory Davis | M | - | 4 years | |
| Robert Carey | M | 65 | 8 years | |
| David Allison | M | 42 | 5 years | |
| Kenneth Hillan | M | 63 | 4 years | |
| Dean C. Allen | M | - |
Global Partnerships
Global Partnerships Financial ConglomeratesFinance Global Partnerships invests in partnerships with local organizations that use market-based solutions for people living in poverty. The firm invests in the areas such as health services, rural livelihoods, green technology and microentrepreneurship. The company was founded by Paula Clapp and Bill Clapp in 1994 and is headquartered in Seattle, WA. | - |
| Yves Leurquin | M | - |
Inventprise LLC
Inventprise LLC Pharmaceuticals: MajorHealth Technology Inventprise LLC is a private company that is developing vaccines against infectious diseases, with a focus on invasive pneumococcal disease, using their innovative platform technology. The company is based in Redmond, WA. The company also offers contract services in biologics, including process development, optimization, analytical services, and manufacturing from early clinical trials through commercialization. The company was founded by Subhash Vinayak Kapre, who has been the CEO since incorporation. | - |
| Amy Pooler | F | - | - | |
| Massimo Radaelli | M | 65 |
Infectious Disease Research Institute
Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Infectious Disease Research Institute operates as a innovative science to research and development company. It offers pipeline, adjuvants, vaccines, diagnostics and drugs products. The firm also provides manufacturing, analytical methods, stability studies, process and contact services. The company was founded by Steven G. Reed in 1993 and is headquartered in Seattle, WA. | 12 years |
| Courtney Beers | M | 54 | 2 years | |
| Gail DeGiulio | F | - |
Global Partnerships
Global Partnerships Financial ConglomeratesFinance Global Partnerships invests in partnerships with local organizations that use market-based solutions for people living in poverty. The firm invests in the areas such as health services, rural livelihoods, green technology and microentrepreneurship. The company was founded by Paula Clapp and Bill Clapp in 1994 and is headquartered in Seattle, WA. | - |
| Rick Beckett | M | - |
Global Partnerships
Global Partnerships Financial ConglomeratesFinance Global Partnerships invests in partnerships with local organizations that use market-based solutions for people living in poverty. The firm invests in the areas such as health services, rural livelihoods, green technology and microentrepreneurship. The company was founded by Paula Clapp and Bill Clapp in 1994 and is headquartered in Seattle, WA. | - |
| Nathalie Dubois Stringfellow | M | - | 5 years | |
| Kristina Allikmets | M | - |
StrideBio, Inc.
StrideBio, Inc. BiotechnologyHealth Technology Stridebio, Inc. focuses on creating and developing novel adeno-associated viral vector technologies. The company was founded by Aravind Asokan, Mavis Agbandje-McKenna and Patrick Ritschel and is headquartered in Durham, NC. | - |
| Karen Frechou-Armijo | F | - | 3 years | |
| Stephen Brown Davis | M | 66 |
Global Partnerships
Global Partnerships Financial ConglomeratesFinance Global Partnerships invests in partnerships with local organizations that use market-based solutions for people living in poverty. The firm invests in the areas such as health services, rural livelihoods, green technology and microentrepreneurship. The company was founded by Paula Clapp and Bill Clapp in 1994 and is headquartered in Seattle, WA. | - |
| Jason Henning | M | - |
Global Partnerships
Global Partnerships Financial ConglomeratesFinance Global Partnerships invests in partnerships with local organizations that use market-based solutions for people living in poverty. The firm invests in the areas such as health services, rural livelihoods, green technology and microentrepreneurship. The company was founded by Paula Clapp and Bill Clapp in 1994 and is headquartered in Seattle, WA. | 20 years |
| Kusi Hornberger | M | - |
Global Partnerships
Global Partnerships Financial ConglomeratesFinance Global Partnerships invests in partnerships with local organizations that use market-based solutions for people living in poverty. The firm invests in the areas such as health services, rural livelihoods, green technology and microentrepreneurship. The company was founded by Paula Clapp and Bill Clapp in 1994 and is headquartered in Seattle, WA. | 9 years |
| Maggie Walker | F | - |
Global Partnerships
Global Partnerships Financial ConglomeratesFinance Global Partnerships invests in partnerships with local organizations that use market-based solutions for people living in poverty. The firm invests in the areas such as health services, rural livelihoods, green technology and microentrepreneurship. The company was founded by Paula Clapp and Bill Clapp in 1994 and is headquartered in Seattle, WA. | - |
| Mina Pastagia | M | - | 4 years | |
| Jerry Wan | M | 42 | 7 years | |
| Jaime Xinos | F | - | 7 years | |
| Walter Euyang | M | - |
Global Partnerships
Global Partnerships Financial ConglomeratesFinance Global Partnerships invests in partnerships with local organizations that use market-based solutions for people living in poverty. The firm invests in the areas such as health services, rural livelihoods, green technology and microentrepreneurship. The company was founded by Paula Clapp and Bill Clapp in 1994 and is headquartered in Seattle, WA. | - |
| Tessa Keating | F | - |
Global Partnerships
Global Partnerships Financial ConglomeratesFinance Global Partnerships invests in partnerships with local organizations that use market-based solutions for people living in poverty. The firm invests in the areas such as health services, rural livelihoods, green technology and microentrepreneurship. The company was founded by Paula Clapp and Bill Clapp in 1994 and is headquartered in Seattle, WA. | - |
| Beth Randall | F | - |
Global Partnerships
Global Partnerships Financial ConglomeratesFinance Global Partnerships invests in partnerships with local organizations that use market-based solutions for people living in poverty. The firm invests in the areas such as health services, rural livelihoods, green technology and microentrepreneurship. The company was founded by Paula Clapp and Bill Clapp in 1994 and is headquartered in Seattle, WA. | 18 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jeremy Curnock-Cook | M | 75 |
AmpliPhi Biosciences Corp.
 AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | 25 years |
| James Johnson | M | 67 |
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA.
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | 18 years |
| Todd R. Patrick | M | 61 |
C3J Therapeutics, Inc.
C3J Therapeutics, Inc. BiotechnologyHealth Technology C3J Therapeutics, Inc. operates as a biotechnology company. It focuses on the discovery and development of novel targeted antimicrobials-synthetic bacteriophage and antimicrobial peptides. The company was founded by Randal Eckert, Maxwell H. Anderson and Wenyuan Shi in 2005 and is headquartered in Marina del Rey, CA. | 13 years |
| Edward O. Lanphier | M | 67 | 22 years | |
| Michael Perry | M | 64 |
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | 15 years |
| Brian Varnum | M | 64 |
C3J Therapeutics, Inc.
C3J Therapeutics, Inc. BiotechnologyHealth Technology C3J Therapeutics, Inc. operates as a biotechnology company. It focuses on the discovery and development of novel targeted antimicrobials-synthetic bacteriophage and antimicrobial peptides. The company was founded by Randal Eckert, Maxwell H. Anderson and Wenyuan Shi in 2005 and is headquartered in Marina del Rey, CA. | 4 years |
| Todd Simpson | M | 63 |
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | 9 years |
| Steven Gillis | M | 71 |
Immunex Corp.
Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | 13 years |
| Rajiv Amin | M | 48 | - | |
| Jon Congleton | M | 60 | 3 years | |
| John Nicols | M | 60 | 11 years | |
| Adrian Adams | M | 73 | 3 years | |
| William Ringo | M | 78 | 8 years | |
| Gary Loeb | M | 54 | 2 years | |
| Kathy Yi | F | 52 | 2 years | |
| David J. Poston | M | 61 |
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | - |
| Steven Martin | M | 63 | 3 years | |
| Leonard Paolillo | M | 45 | 3 years | |
| John Leaman | M | 51 | 4 years | |
| Chris Browning | M | - |
University of Washington
University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | 5 years |
| Karl A. Schoene | M | - | 3 years | |
| Eric Easom | M | 56 |
Infectious Disease Research Institute
Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Infectious Disease Research Institute operates as a innovative science to research and development company. It offers pipeline, adjuvants, vaccines, diagnostics and drugs products. The firm also provides manufacturing, analytical methods, stability studies, process and contact services. The company was founded by Steven G. Reed in 1993 and is headquartered in Seattle, WA. | 7 years |
| Franz L. Pool | M | - |
University of Washington
University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | 4 years |
| McDavid Stilwell | M | 53 | - | |
| Martin Mattingly | M | 66 | 13 years | |
| Ross Taylor | M | 60 | 4 years | |
| Douglas G. Beck | M | - |
University of Washington
University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | 4 years |
| Larry Dale Kinner | M | 71 |
University of Washington
University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | 6 years |
| Caroline Loewy | F | 58 | 26 years | |
| Adam Leight | M | 67 |
University of Washington
University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | 6 years |
| C. Boyd Clarke | M | 74 |
Neose Technologies, Inc.
 Neose Technologies, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to develop proprietary drugs, focusing primarily on therapeutic proteins. Its technologies to develop proprietary versions of protein drugs with proven safety and efficacy and to improve the therapeutic profiles of proteins being developed. Its proprietary drug development portfolio currently consists of two therapeutic protein candidates.GlycoPEG-EPO (NE-180) is a long-acting version of erythropoietin (EPO) produced in insect cells. EPO is prescribed to stimulate production of red blood cells, and it gives treatment of chemotherapy-induced anemia and anemia associated with chronic renal failure. Its second proprietary protein, GlycoPEG-GCSF, is a long-acting version of granulocyte colony stimulating factor G-CSF and it is prescribed to stimulate production of neutrophils (a type of white blood cell). Its trademarks are NEOSE, GlycoPEGylation and GlycoConjugation. It operates predominantly in the domestic market. | 5 years |
| Jay Moyes | M | 70 | 6 years | |
| Kenneth Hobbs | M | 65 |
University of Washington
University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | 7 years |
| David A. Spurling | M | 71 |
University of Washington
University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | 6 years |
| Donald Joseph | M | 70 | 6 years | |
| Patrick Yang | M | 75 | 9 years | |
| Blair Brumley | M | - |
University of Washington
University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 90 | 90.00% |
| Canada | 10 | 10.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- H. Parker
- Personal Network
